REFRACTORY MENINGIOMA

Clinical trials for REFRACTORY MENINGIOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MENINGIOMA trials appear

Sign up with your email to follow new studies for REFRACTORY MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Brain tumor drug trial halted before starting

Disease control Terminated

This study aimed to learn about a drug called ONC201 for people with a type of brain tumor (meningioma) that had come back or stopped responding to other treatments. It planned to test the drug in two groups: people scheduled for surgery and people with no other treatment options…

Matched conditions: REFRACTORY MENINGIOMA

Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

REFRACTORY MENINGIOMA

Get alerted when new REFRACTORY MENINGIOMA trials appear

Brain tumor drug trial halted before starting